Gandira (Clerodendrum phlomidis)

Gandira (Clerodendrum phlomidis) is an Ayurvedic shrub containing bioactive iridoid glycosides, flavonoids, and clerodane diterpenes that drive its therapeutic activity. These compounds exert antioxidant, anti-inflammatory, and mucolytic effects primarily by scavenging free radicals and modulating inflammatory mediator pathways.

Origin & History

Gandira, scientifically known as Clerodendrum phlomidis, is a shrub native to India and utilized in Ayurvedic medicine. The plant's medicinal properties are derived from its leaves, roots, bark, and stems, which are typically processed through alcoholic or aqueous extraction methods.

Historical & Cultural Context

In Ayurveda, Clerodendrum phlomidis is traditionally used as a kapha-vata pacifier for conditions such as inflammation, asthma, and diabetes. Its applications include root decoctions for painful urination and warm leaf applications for pain relief.

Health Benefits

• May improve sputum clearance by 40% in chronic bronchitis subjects (small-scale report lacking details).
• Reduces joint swelling by 35% in animal models (2015 study in rats).
• Exhibits 60% DPPH radical reduction in in vitro assays indicating antioxidant potential.
• Provides antimicrobial effects with inhibition zones of 12–15 mm against S. aureus and E. coli.
• Preliminary trials note modest white blood cell boosts, though lacking specifics.

How It Works

Clerodane diterpenes and flavonoids in Clerodendrum phlomidis inhibit cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing prostaglandin and leukotriene synthesis that drives joint inflammation. Iridoid glycosides appear to modulate NF-κB signaling, suppressing downstream pro-inflammatory cytokines such as TNF-α and IL-6. Phenolic compounds including luteolin and apigenin contribute to DPPH and ABTS radical scavenging, protecting cellular membranes from oxidative degradation.

Scientific Research

There are no large-scale human randomized controlled trials or meta-analyses available for Clerodendrum phlomidis. Current evidence consists mainly of preclinical animal studies and in vitro assays. A small-scale report from Pune University mentions a 2018 study on sputum clearance but lacks detailed documentation.

Clinical Summary

Evidence for Gandira remains preliminary and largely preclinical. A 2015 rat model study reported approximately 35% reduction in carrageenan-induced paw edema, suggesting anti-inflammatory activity, though rodent models do not reliably translate to human outcomes. A small-scale human report in chronic bronchitis subjects noted roughly 40% improvement in sputum clearance, but methodological details including sample size, controls, and blinding are absent, severely limiting interpretability. In vitro DPPH assays demonstrated 60% radical neutralization, indicating antioxidant potential that requires validation in cell-based and clinical settings before meaningful conclusions can be drawn.

Nutritional Profile

Gandira (Clerodendrum phlomidis) is not consumed as a food source, so conventional macronutrient profiling (calories, protein, fat, carbohydrates) is not typically established. Its relevance lies in its phytochemical and bioactive compound profile rather than dietary nutrition. Key constituents include: **Flavonoids**: Pectolinarigenin (~0.02–0.08% w/w of dried leaf/root), hispidulin, and scutellarein — responsible for antioxidant (60% DPPH radical scavenging) and anti-inflammatory activities. **Phenolic acids**: Caffeic acid, ferulic acid, and gallic acid (total phenolic content approximately 45–65 mg GAE/g of dried extract), contributing to free-radical neutralization. **Terpenoids & sterols**: Clerosterol, β-sitosterol (~0.1–0.3% w/w), and lupeol — associated with anti-inflammatory and hepatoprotective effects. **Iridoid glycosides**: Phlomidoside and related compounds (estimated 0.5–1.2% w/w in root bark), considered among the signature bioactives linked to mucolytic and bronchodilatory properties. **Saponins**: Present in moderate concentration (~1–3% w/w in root), contributing to expectorant activity and antimicrobial effects (12–15 mm inhibition zones against S. aureus and E. coli). **Alkaloids**: Trace amounts detected in leaves and stems. **Tannins**: Approximately 2–4% w/w in bark, providing astringent and antimicrobial properties. **Minerals (from ash analysis of whole plant)**: Calcium (~800–1200 mg/100 g dry weight), potassium (~600–900 mg/100 g), iron (~8–15 mg/100 g), magnesium (~200–350 mg/100 g), and zinc (~3–6 mg/100 g) — though these values are from dried plant material not intended for dietary intake. **Crude fiber**: ~18–25% in dried aerial parts. **Crude protein**: ~6–10% in dried leaf material (primarily structural, not nutritionally targeted). **Vitamins**: Ascorbic acid detected in fresh leaves (~15–30 mg/100 g fresh weight); minor amounts of B-complex vitamins reported qualitatively. **Bioavailability notes**: The iridoid glycosides and flavonoid glycosides have limited oral bioavailability (~5–15% estimated) due to first-pass metabolism and poor lipid solubility; traditional Ayurvedic formulations (kwatha/decoction, churna with ghee or honey as anupana) are designed to enhance absorption. β-sitosterol bioavailability is inherently low (~5–10%) but may be improved when administered with lipid-based vehicles (ghrita preparations). Pectolinarigenin undergoes glucuronidation, further limiting systemic availability unless formulated appropriately.

Preparation & Dosage

No clinically studied dosage ranges are available. Traditional uses include decoctions of roots for diabetes and leaf extracts for respiratory support. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginger, licorice, cumin

Safety & Interactions

No large-scale human safety trials for Clerodendrum phlomidis have been published, making a comprehensive adverse-effect profile unavailable. Given its COX/LOX inhibitory activity, concurrent use with NSAIDs, anticoagulants such as warfarin, or antiplatelet drugs may theoretically potentiate bleeding risk and should be approached with caution. Pregnancy and lactation safety data are entirely absent, and use in these populations is not supported by current evidence. Individuals with autoimmune conditions or those on immunosuppressive therapy should consult a healthcare provider before use.